Chengguan District, Lanzhou, Gansu, China sales01@liwei-chem.com 1557459043@qq.com
Follow us:



Yeast and Oat β-Glucan: Pharma Grade Article

Historical Development

The story of β-glucan starts in the 1940s. Scientists first noticed this molecule in bread yeast, linking it to immune support in clinical research about a decade later. In the early days, folk remedies used oats and barley for skin and stomach issues, long before researchers assigned labels or formulas. Focus on β-glucan increased after Japanese teams isolated lentinan from shiitake mushroom for cancer studies. Then came interest from Europe and the United States, fueled by advances in chromatography and molecular biology. By the late 20th century, suppliers turned brewing and baking byproducts into functional ingredients. Turning yeast waste into pharmaceutical-grade β-glucan marks a shift from niche supplement to global commodity for health, driven by an understanding that certain β-glucans offer measurable benefits for cholesterol and immune function backed by decades of published data.

Product Overview

β-Glucan Pharma Grade refers to a purified polysaccharide sourced either from yeast (Saccharomyces cerevisiae) or from oat fiber. Refined for pharmaceutical manufacturing, this material prioritizes batch-to-batch consistency with minimal protein, endotoxin, or heavy metal contamination. Manufacturers define grades under compendia such as British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP). Large-scale fermenters harvest Saccharomyces yeast, crack open the cell walls, and extract β-glucans using a mix of heat, mechanical disruption, and food-safe enzymes. Oat β-glucan comes from the bran using water extraction. Finished product from either source is usually an off-white powder, free-flowing, with a neutral taste, suitable for clinical trials and oral dosage forms. Leading suppliers package the powder in sealed drums, with batch certificates laying out purity, moisture content, and microbiological data.

Physical & Chemical Properties

β-Glucan molecules form long chains of glucose linked mainly by β-1,3 and β-1,6 bonds in yeast, while oats produce β-1,3/1,4 linkages. This subtle difference gives yeast and oat β-glucans unique structural backbones. Yeast β-glucan has a slightly higher molecular weight and presents as larger aggregates, making it less soluble in cold water. Oat β-glucan, shorter and more linear, dissolves easily and increases viscosity even at low inclusion levels. Typical yeast β-glucans are partly amorphous, showing up as fibers or granules under electron microscopy. They tend to be white to pale cream in appearance, almost odorless, not sweet, and stable at room temperature for years if kept dry. Both versions display resistance to acid and enzyme breakdown in the upper stomach, only releasing glucose slowly under prolonged digestion.

Technical Specifications & Labeling

Pharma grade β-glucan standards require strict controls. Typical specifications demand a minimum 70% β-glucan content by dry weight, with limits for protein under 2%, moisture below 8%, and microbial counts less than 1000 CFU/g. Lead, cadmium, arsenic, and other toxic element levels must fall well below pharmacopeial thresholds—sometimes less than 0.1 ppm. Each lot has complete traceability from raw material to packaged product. Packaging labels list the main ingredient (“β-Glucan (from Saccharomyces cerevisiae)” or “Oat β-Glucan”), appearance, batch and lot numbers, storage recommendations, and a shelf life guarantee based on real-time stability studies. Certificate of Analysis provided per batch includes β-glucan assay, identity by HPTLC or HPLC, pH, loss on drying, and endotoxin level, in line with BP, EP, and USP monographs.

Preparation Method

Manufacturers start by fermenting yeast under controlled conditions using sugar-rich broth. After fermentation, they disrupt cell walls with pressure, enzymes, or bead mills to release polysaccharide-rich material. Repeated washing steps remove proteins, lipids, and nucleic acids. Next, hot water or mild alkaline treatments solubilize the β-glucan fraction. Filtration, precipitation, and alcohol washing eliminate remaining impurities. The purified β-glucan dries under vacuum and milled to achieve the required particle size. Oat β-glucan extraction relies on water or enzymatic treatment of oat bran, followed by separation and drying. Downstream steps often involve micronization or granulation to suit tablet or capsule manufacturing. Critical control points at every stage keep the final product free of allergens and contaminants, suitable for human ingestion at medicine-grade quality.

Chemical Reactions & Modifications

Chemists have learned to manipulate β-glucan chains for research and medicine. Sulfation increases solubility and imparts anticoagulant properties, allowing exploration as an antithrombotic agent in preclinical studies. Carboxymethylation enhances dispersibility for injectable use. Enzymatic trimming of β-glucan can reduce viscosity and tailor immune-modulating effects by exposing more of the active side chains. Researchers also attach β-glucan to nanoparticle carriers for targeted drug delivery and vaccine development. Each modification introduces changes in molecular weight, solubility, and biological effect, opening the door to customized therapies that use the natural polysaccharide backbone as a core scaffold.

Synonyms & Product Names

Common commercial and technical terms include β-1,3/1,6-glucan, yeast cell wall glucan, baker’s yeast β-glucan, oat β-D-glucan, cellulose gum (for some forms), and names such as Betafectin, Wellmune, and Glucagel for specific products. In pharmacopoeias, it might appear as "Saccharomyces cerevisiae β-glucan extract" or "Avena sativa β-glucan." Trade names reflect manufacturer branding, grade, degree of purification, and target application, but the core structure—a complex carbohydrate chain derived from yeast or oats—remains constant across categories.

Safety & Operational Standards

Pharmaceutical β-glucan complies with Good Manufacturing Practice (GMP) and Hazard Analysis Critical Control Point (HACCP) protocols. Raw materials, facility sanitation, and water sources are tightly controlled to avoid microbial and chemical cross-contamination. Regulatory agencies require comprehensive documentation from source traceability through release testing. Bulk and final packaging use food-grade, inert liners in air-tight containers to prevent oxidation or moisture uptake. Safety data sheets classify β-glucan as non-toxic and non-irritant under normal conditions, though inhalation of powder can trigger mild respiratory discomfort in sensitive workers. Facilities provide appropriate personal protective equipment (PPE) and regular audit schedules for compliance. Every manufacturer must respond quickly to new data about allergies or unintended trace contaminants, recalling or holding stock if any lot goes out of specification.

Application Area

Clinicians, nutritionists, and product developers rely on β-glucan as an immune stimulant, prebiotic fiber, cholesterol-lowering aid, and texturizer. Oral solid dose forms—tablets, capsules, sachets—feature prominently in nutraceuticals and functional foods. Injectable forms and topical gels have found early use in wound care, oncology supportive care, and chronic infection trials. β-glucan also supports beneficial gut microbiota and acts as a viscosity modifier in enteral nutrition formulas. Hospitals use β-glucan-based dressings for burns and ulcers, capitalizing on its mild immune activation for better healing. As regulatory agencies approve health claims around cholesterol reduction for soluble oat β-glucan, formulators include it in foods, shakes, bars, and even beverages.

Research & Development

Industry and academia continually examine the structure-activity relationship of β-glucan polymer length, branching pattern, and purity. Mouse, pig, and primate trials have shaped understanding of dosing and immune impact. Investigators now examine how yeast versus oat sources affect microbiome shifts, vaccine response, and antiviral resistance in humans. Engineers are developing new fermentation strains with higher β-glucan output or more favorable bond ratios. Collaborations between pharmaceutical firms and biotech startups test novel delivery routes—soluble sprays, intranasal drops, biodegradable implants—that stretch practical applications beyond current formats. Synthetic biology approaches offer designer β-glucans, produced in vitro with precisely controlled size, branching, and functional groups. Hundreds of peer-reviewed articles emphasize not just efficacy but standardization, safety, and optimal dose.

Toxicity Research

Safety has long been front and center for pharmaceutical-grade β-glucan. Multiple animal studies over the past twenty years report a no-observed-adverse-effect level (NOAEL) at intakes up to 2000 mg/kg/day. Human tolerance trials, including those with atopic or immune-compromised volunteers, usually show no increase in side effects at suggested doses. Occasional gastrointestinal upset appears in large bolus dosing but disappears after dose adjustment or with divided administration. Long-term follow-ups in cholesterol and allergy studies do not associate β-glucan intake with changes in hematology, liver, or renal indices. Post-marketing surveillance tracks allergy and cross-reactivity with gluten and chitin, but published incident rates remain extremely low. Regulatory authorities assign β-glucan ingredients “Generally Recognized As Safe” (GRAS) status in food, and pharmaceutical monograph approval in Europe, North America, and Asia.

Future Prospects

β-Glucan’s future opens up as biomedical research dives into “trained immunity”—the ability of innate immune cells to develop memory-like responses after exposure to potent molecules like β-glucan. Next-generation delivery systems may see β-glucan loaded with RNA drugs, vaccines, or anti-cancer compounds, using its receptor-targeting features to guide therapies to immune cells. Advances in fermentation and extraction technology will likely drop costs, making β-glucan accessible to more global manufacturers and smaller biotech players. A shift towards green and circular economy models brings new value to byproducts from brewing and oat processing, closing waste loops and adding environmental sustainability to the equation. Expect regulatory groups to fine-tune definitions and labeling, moving toward global harmonization and transparent supply chains, which becomes crucial as β-glucan reaches billions of consumers worldwide in formats far removed from yeast or oats.




What is Yeast/Oat β-Glucan BP EP USP Pharma Grade used for?

What Sets Pharma Grade β-Glucan Apart?

β-Glucan shows up on ingredient lists much more often than people realize, though most folks run into it at breakfast before they see it on medication labels. Yeast and oat β-glucans have a spot in the pharmaceutical world because these natural fibers have a record of doing more than just filling up cereals and loaves of bread. They shape how our bodies respond to infections, how fast wounds heal, and even how some drugs work. Sourcing matters—only pharma grade, which meets tough purity standards (including BP, EP, USP monographs), works for medicine. Contaminants, molds, and leftover proteins get weeded out long before these end up in capsules and creams.

Immune Modulation—The Real Draw

Doctors recognize β-glucan for its unique effect on the immune system. Tons of clinical studies and research track how these fibers "teach" immune cells to respond better. Kids, elders, and patients fighting tough infections or cancer often take immune support seriously. Certain white blood cells, like macrophages, grab on to β-glucan and start signaling the rest of the immune system. This doesn’t mean β-glucan acts as a cure, but multiple reviews in journals like Frontiers in Immunology point to fewer upper respiratory infections and stronger vaccine responses in people given regular doses of high-quality β-glucan.

Pharmaceutical Formulations and Beyond

Drug companies reach for β-glucan to get both therapeutic and functional benefits. In tablet form, β-glucan helps control drug release and can stabilize tricky active ingredients. It also thickens and smooths topical creams and gels. Yeast and oat β-glucan sometimes partner up with antibiotics, wound dressings, and even eye drops. My own time working in pharmacy compounding showed that a stable gel base doesn’t just hold up better—it lets the medication touch skin more evenly and reduces redness, likely from β-glucan’s calming properties. Hospitals use β-glucan dressings for slow-healing wounds in diabetic and cancer patients, reducing time to closure and cutting down on repeat infections, according to real-world studies by wound care specialists.

Gut Health and Prebiotic Advantages

Gut health grabs headlines, but few realize the pharmacy shelves carry β-glucan supplements for patients with bowel disease, chronic constipation, or those on repeat antibiotics. Doctors appreciate how β-glucan feeds good bacteria in the intestines, boosting those short-chain fatty acids the colon cells thrive on. Regular intake improves stool consistency and cuts down on flare-ups in patients with irritable bowel syndrome, confirmed by review articles in European Journal of Nutrition.

Where the Risks and Solutions Lie

Not every β-glucan on the market fits the strict definition needed for pharmaceutical products. Sourcing low-quality fiber risks contamination, allergic reactions, or weak clinical effects. Regulators like the FDA spell out limits for heavy metals and microbes in standardized monographs. Patients—especially those who are immunocompromised—deserve transparency. Pharmacies and manufacturers must show batch analysis and traceable sourcing up front. Doctors want branded raw material with clean Certificates of Analysis—no shortcuts, no dusty repackaged oat powder.

Room for Improvement

Some patients ask about β-glucan and find only wellness blogs or supplement ads. Medical training doesn’t always cover these natural fibers in detail, so better education could bridge the gap. Hospitals and community pharmacies can ensure product quality, offer third-party verified β-glucan, and keep records transparent. In the end, pharmaceuticals only succeed when reliability matches patient need. Standardized, thoroughly tested β-glucan goes beyond “natural” marketing and earns a place in therapy regimens that are based on facts, not just fads.

Is Yeast/Oat β-Glucan BP EP USP Pharma Grade safe for human consumption?

What Is Yeast/Oat β-Glucan Pharma Grade?

Yeast and oat β-glucan aren't fresh names in health circles. If you've sprinkled oat bran on yogurt or checked nutrition labels, odds are you've seen β-glucan. This natural fiber lives in the cell walls of cereals like oats and barley, and in baker’s yeast. Pharma-grade β-glucan has stricter quality checks and more defined standards compared to food-grade versions, which means consistency in purity and structure, batch after batch. The “BP,” “EP,” and “USP” tags stand for British, European, and United States Pharmacopeia, representing some of the highest quality benchmarks for pharmaceutical ingredients worldwide.

Looking At the Evidence

Most people are already eating small amounts of β-glucan from their cereals, mushrooms, or bread. Agencies like the European Food Safety Authority and the US Food and Drug Administration recognize oat β-glucan as a safe fiber that can help with cholesterol levels. Studies link regular intake to lower blood cholesterol and steadier blood sugar after meals. Pharmacopeia-grade β-glucan means the stuff you find meets or beats purity requirements — so you’re not getting unwanted contaminants.

Because pharma grade gets regulated carefully, the potential for allergens and impurities is minimized. For example, I always check supplement labels for purity when buying for my family. Food supplements with the BP, EP, or USP marks reliably come from companies following traceable and safe processing steps. My experience shows that careful sourcing makes a difference, especially when it comes to products that claim health benefits.

Side Effects and Cautions

Eating β-glucan through whole foods can bloat sensitive bellies, especially if fiber intake jumps suddenly. The pharmacy grade often comes in capsules or powder, which makes dosing manageable. Most healthy adults tolerate up to 3 grams daily, based on clinical trials. Anything more tends to lead to some stomach rumbling, so gradual adjustment is key. Those with celiac disease or gluten sensitivity can choose yeast β-glucan, which hasn’t come from gluten-producing grains. Oat-derived versions labeled BP, EP, or USP generally test below gluten safety thresholds, but double-checking with the producer provides extra peace of mind.

Immune-compromised individuals or people on special medication regimens should always speak with their doctor before adding high doses of functional fibers. Some animal studies flag that overdoing β-glucan can overstimulate the immune system. Human studies suggest a safe track record, but the best bet involves sticking to indicated dosages.

Building Trust in Ingredients

Consumers want to know where their supplements come from, and with good reason. I travel often and notice how standards for what “pharma grade” means can shift by country. The big Pharma Codexes — BP, EP, USP — standardize that: offering third-party verification, product recall systems, and transparent traceability from factory to pharmacy shelf. Brands that carry these marks often publish batch analyses and testing data in plain language. That level of transparency helps people make informed decisions about what goes into their bodies.

Keeping Safe and Making Smart Choices

A quality seal doesn’t excuse reckless self-dosing, but it does offer more confidence that what you’re taking is what’s on the bottle. For everyday wellness, β-glucan earned its reputation through hearty oat breakfasts and yeast-leavened breads long before it became a pharma ingredient. Today, the rigorous quality checks, clear regulations, and decades of research stand behind its safety for most healthy adults when used as directed. Checking with healthcare professionals remains smart, especially for people managing chronic health conditions or allergies.

What is the typical dosage and administration of this Pharma Grade β-Glucan?

The Role of β-Glucan in Health

Pharma grade β-glucan often comes up in conversations about immune support, metabolic health, or even in hospital nutrition. In my own experience reading clinical guidelines, there’s no denying how much attention this polysaccharide has received from researchers and doctors alike. With more supplement bottles and even food products now listing it among their ingredients, clarity about usage and proper dosing feels more important than ever—not just for scientists, but for regular folks too.

Dosing in Scientific Studies

When doctors recommend β-glucan, they usually base their advice on trials with standardized extracts. Daily doses ranged from 250 mg to 1000 mg in many published studies. Most evidence-backed immune benefits landed in that 500 mg to 750 mg range. It’s tough to make sense of conflicting advice found online or on different packages. The guiding principle: dose depends on the goal. For immune system support, 500 mg is a common choice. Someone recovering from illness might try up to 1000 mg, but those situations almost always include doctor supervision.

Administration Details Matter

Oral administration stands out as the most practical path. Capsules, powders mixed into liquids, and even enriched food products line pharmacy shelves. Healthcare workers I know stress the importance of timing: taking it with food can help some people avoid mild stomach upset. Hydration also matters—drinking water with β-glucan aids its gentle trip through the gut.

Intravenous use of β-glucan happens mostly in hospitals and clinical trials, rather than home settings, for conditions like wound healing or adjunctive therapy in oncology. Most people never need to think about this method. Even in clinical care, the focus lands squarely on safety and observation, not convenience.

Who Should Take Caution?

Some groups cannot safely experiment with these supplements. Children, pregnant women, and anyone with chronic immune disorders should check with their physician. Allergies or dietary restrictions make it crucial to read ingredient lists; many β-glucan products come from oats or barley, so patients with celiac disease or gluten sensitivity should look for yeast-derived sources.

Fact-Checking Product Labels

Navigating supplement aisles grows confusing fast. Not every bottle meets ‘pharma grade’—a term that only means something if backed by certificates and lot numbers. Labels showing standardized purity and sources give peace of mind. Brands boasting third-party testing and clinical-familiar manufacturing processes earn more trust.

Potential Paths for Better Dosing

To sort out the noise, I’d argue for clearer rules from regulators—that’s what empowers both patients and the doctors guiding them. Physicians need access to training on supplement uses, not just prescription drugs. Offering easy, up-to-date access to clinical trial databases would save everyone time.

If more companies published transparent batch analyses, confusion would fade a bit. Until then, I lean into listening to trusted doctors and checking scientific sources—the approach that always seemed to work well for me and my family.

How is Yeast/Oat β-Glucan BP EP USP Pharma Grade different from food-grade β-Glucan?

What Sets Pharma Grade β-Glucan Apart?

Digging into β-Glucan, especially when comparing pharma grade like BP, EP, or USP to food-grade types, the gap runs deeper than a difference in price tags. Everything flows from quality, safety, and how strictly controls line up—much like comparing the hygiene in a hospital operating room to a busy home kitchen.

The Source and the Story

Both grades pull from oats or yeast, but the moment raw material gets to the factory, pharma-grade production shifts gears. For one thing, every batch leaves a longer paper trail. Suppliers screen more aggressively for contaminants, starting right at the farm or fermenter. Microorganisms, pesticide residues, and heavy metals can leave a trace in food, but in pharma grade, they’re kicked out by more demanding checks.

Science backs up this need. Studies shared in journals like Current Pharmaceutical Design highlight how even a flea-sized level of endotoxin or a hidden allergen can disrupt research or spark reactions in patients getting medicines or injections. No manufacturer using β-Glucan for tablets or IV drips wants a rogue impurity sneaking in.

Purity: The Crossover Point

Let’s talk numbers. Pharma-grade β-Glucan often tests above 95% purity. Food-grade hovers lower—sometimes 70% or less—because that’s enough for supplements or cereal toppings, not for an active pharmaceutical ingredient (API).

Just eating a bowl of oat bran, you won’t blink at a bit of protein or starch alongside the fiber. Swallowing a capsule aimed at modulating immune response for cancer or post-surgery care? Doctors, and more importantly, patients, deserve to see exactly what’s inside. Pharma regulations insist on this, since quality can draw the line between a treatment working as planned or running into trouble.

Sterility and Stability

Another big divider: sterility. Food-grade β-Glucan stays “clean” by regular standards, but pharma grade follows rules that border on obsessive. For injectables, there’s zero tolerance for bacteria, endotoxins, or anything alive. Even for tablets, pharma standards keep a tight rein on the water content and packaging, so the ingredient stays stable—not crumbling, going rancid, or changing color in the bottle.

Testing, Traceability and Trust

Regulators like the FDA, EMA, and those who create BP, EP, and USP rules demand full traceability. Labs run high-performance liquid chromatography (HPLC), mass spectrometry, even DNA fingerprinting to prove consistency and identity batch to batch.

Food-grade β-Glucan, on the other hand, follows national food laws. Those laws stick to safe, nutritious, and legal for sale parameters, but don't extend to the same degree of batch-specific scientific scrutiny.

Customers trust the pharma-grade tag because every shipment comes with certificates for purity, sterility, manufacturing date, and even a recall plan. Hospitals and pharmaceutical firms can spot a weak link, stop a shipment, and quarantine product—all the steps in place to avoid a bad outcome.

Can Food Grade Ever Step Up?

In some places, customers try to stretch food-grade β-Glucan for non-food uses, chasing cost savings. The risks outweigh the rewards: product recalls, liability, and—worst—patient harm. Pharma-grade β-Glucan surfaces as the better bet for therapies, vaccines, and drug delivery systems, locking in safety and quality in an area where health doesn’t accept shortcuts.

What are the storage and handling requirements for this product?

Taking Stock of Real-World Risks

Anyone who’s managed supplies in a workplace knows the job doesn’t stop at making an order. It’s all about what you do after the truck leaves. Put the wrong drum on the wrong shelf, and risk creeps in—sometimes quietly, sometimes all at once. Over time, I’ve learned to treat storage and handling rules as non-negotiables, not as extra steps slowing down the day.

Understanding the Product’s Limits

Each product comes with its own quirks. Some don’t fare well in the sun. Others can’t mix with water or humidity without trouble. I’ve worked in warehouses that keep everything from chemicals to frozen meds, and the consistent truth is that shortcuts raise the stakes. The U.S. Occupational Safety and Health Administration (OSHA) highlights this in nearly every citation: safe storage choices save lives and property—not just product quality.

Temperature and Light: The Usual Suspects

If the product breaks down in heat, a low, steady temperature is key. Think about pharmaceuticals or food ingredients. They lose value fast if kept warm for even a day. On the other hand, moisture does its own wiping out. Think flour, adhesives, or any dehydrated material. Keep humidity in check, and there’s much less spoilage or clumping.

Light plays a role, too. Some products degrade with exposure, losing their strength or becoming dangerous—peroxide solutions, for example, weaken or even turn volatile in bright conditions. So I’ve seen the habit of using dark glass containers spread across labs and storage rooms, and for good reason.

Physical Safety and Security

Physical risk never stays theoretical. A heavy barrel up high courts disaster. Flammable liquids parked near ignition sources can turn an afternoon into a news story. Over the years, I’ve heard enough insurance claims to know spacing and stacking rules matter. It’s not just about avoiding broken packages. Keeping aisles clear, stacking at safe heights, and using proper containment cuts down on spills and falls. If a spill does happen, containment trays often mean the difference between a quick sweep-up and a call to emergency services.

Security also matters. Some goods attract thieves or vandals, especially those with resale value. A locked cabinet or a cage isn’t about being over-cautious—it means fewer headaches and less paperwork down the road. Plus, records show break-ins trend lower when items stay out of sight.

Training: The Deciding Factor

No storage plan lasts without people who know the rules. Experienced workers spot a shelf bowing before it fails. They call out damaged containers or leaking valves. The right labels help, but nothing beats a workforce trained to spot and fix problems. Reporting near misses—not hiding them—keeps the site safer for everyone.

Solutions That Pay Off

Some fixes cost money up front, but they always pay back. Automated sensors track temperature, saving spoilage costs. Desiccant packs cut down on moisture damage. Repairing leaks right away prevents small issues from ballooning. These steps turn quality guidelines into everyday practice, not just posters on the wall.

At the end of the month, the payback shows up as fewer losses, less downtime, and lower insurance claims. It isn’t just about following regulatory boxes—these habits protect people and investments. Years in this business have shown me that storing and handling smart means more than keeping things neat; it keeps the work and workers going strong.

Yeast/Oat β-Glucan BP EP USP Pharma Grade
Names
Preferred IUPAC name (1→3),(1→4)-β-D-glucan
Other names Oat Beta-Glucan
Yeast Beta-Glucan
Beta-1,3/1,6-Glucan
β-Glucan
Pharmaceutical Grade Beta Glucan
Pronunciation /jiːstˈəʊt ˌbiːˈɡluːkæn ˌbiːˈpiː ˌiːˈpiː ˌjuːˌɛsˈpiː ˈfɑːrmə ɡreɪd/
Identifiers
CAS Number 9041-22-9
3D model (JSmol) Sorry, I can't provide the '3D model (JSmol)' string for 'Yeast/Oat β-Glucan BP EP USP Pharma Grade'.
Beilstein Reference 95683
ChEBI CHEBI:5351
ChEMBL CHEMBL4296251
ChemSpider 21510311
DrugBank DB11420
ECHA InfoCard ECHA InfoCard: 100.242.932
EC Number 9004-54-0
Gmelin Reference Gmelin Reference: 82518
KEGG C01786
MeSH D013528
PubChem CID 5280974
RTECS number VW0596000
UNII BGF7V5QK78
UN number Not regulated
CompTox Dashboard (EPA) DTXSID3074742
Properties
Chemical formula (C6H10O5)n
Molar mass 194.14 g/mol
Appearance White to almost white, hygroscopic powder
Odor Characteristic
Density 0.3–0.5 g/cm³
Solubility in water Soluble in water
log P -2.49
Acidity (pKa) 5.0–7.0
Basicity (pKb) 8.50 (as string)
Refractive index (nD) 1.333 - 1.360
Viscosity 20-300 cP
Dipole moment 0 D
Thermochemistry
Std enthalpy of combustion (ΔcH⦵298) -16.10 kJ/g
Pharmacology
ATC code A16AX10
Hazards
Main hazards Not a hazardous substance or mixture.
GHS labelling GHS02, GHS07
Pictograms GHS05,GHS07
Signal word Warning
NFPA 704 (fire diamond) NFPA 704: 1-0-0
LD50 (median dose) > 2000 mg/kg
PEL (Permissible) 10 mg/m³
REL (Recommended) 1.5-3.0 g/day
Related compounds
Related compounds Cellulose
Chitin
Lentinan
Laminarin
Dextran
Pullulan
Curdlan
Mannan
Arabinoxylan
Xyloglucan